The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage to avoid the ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

I found that so many people were making their own GLP-1s and taking smaller amounts than normally prescribed,” she said. “I ...

He stumbled across a non-compounding site displaying a bottle of semaglutide marked “not for human consumption ... prescriptions could purchase the drug in 2.5 mg. and 5.0 mg. vials directly from ...

Adverse reactions can be reported to the FDA's MedWatch program. In response to a report of foreign material found in a sealed vial, Alcon Laboratories has initiated a voluntary recall of Lot 10101 of ...

People who use semaglutide, the active ingredient in diabetes and weight-loss medications like Ozempic, face twice the risk of developing a serious eye condition that can lead to blindness, according ...

Strive typically tests its tirzepatide and semaglutide with a third-party analytical company and conducts a months-long ...

"If compounded semaglutide goes away as well ... quality and safety of the product before creating batches of up to 250 vials, he noted. Dr. Mace Scott, the owner and medical director of ...